Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by GunnerGon Jan 27, 2022 1:24pm
114 Views
Post# 34367409

RE:Mister klompas was also director at luminal now

RE:Mister klompas was also director at luminal nowMister klompas has been COO and CFO at Zymeworks since 2007.  Thats 15 yeats.

It is the BOD of Zymeworks that hired Kenneth, not klompas.

You are looking for problems when they do not exist. 

BTW, what was so great about his post?  He provided a link to Zymeworks publice offering, wow..
  
Also, I have been with Prometic/Liminal since 2017 and the valuation has never been close to $6 billion (yes BILLION). Lets see him provide a link to that BS.



edrose wrote: He's going with Galbraith at zymeworks another biotech

look at great post by balain and attached link re biotech zymework

A MUST READ 


<< Previous
Bullboard Posts
Next >>